As of 3:59pm ET
| +0.01 / +0.52%|
The 6 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 17.00 and a low estimate of 4.00. The median estimate represents a +236.79% increase from the last price of 1.93.
The current consensus among 6 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.